Sign in
4

Changes in Ownership

10x Genomics, Inc. Filed Acc 0001209191-21-036104

Chief Executive Officer sold 771 shares at $162.66 ($125,411)

  • Chief Executive Officer acquired 24,571 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Saxonov Serge · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-03-19 Grant or award : show line 1 in the form +24,571 905,039 D
2021-05-24 Sale : show line 2 in the form −771 $162.66 $125,411 904,268 D
Open-market sales · 771 sh · avg $162.66 · $125,411

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-03-19 Grant or award : show line 3 in the form Stock Option (right to buy) +61,428 $177.76 2031-03-19 61,428 61,428 D
Loading xslF345X03/doc4.xml…